Oncolys BioPharma Market Cap

Oncolys BioPharma has a market cap or net worth of 54.83 billion as of February 6, 2026. Its market cap has increased by 326.49% in one year.

Market Cap

54.83B

Enterprise Value

53.82B

Revenue

28.55M

Ranking

n/a

PE Ratio

n/a

Stock Price

1,873.00

Market Cap Chart

Since December 6, 2013, Oncolys BioPharma's market cap has increased from 23.62B to 54.83B, an increase of 132.15%. That is a compound annual growth rate of 7.16%.

Market Cap History

Date	Market Cap	% Change
Feb 6, 2026	54.83B	38.50%
Dec 30, 2025	39.59B	207.33%
Dec 30, 2024	12.88B	18.41%
Dec 29, 2023	10.88B	19.14%
Dec 30, 2022	9.13B	-0.44%
Dec 30, 2021	9.17B	-58.26%
Dec 30, 2020	Upgrade Pro	Upgrade Pro
Dec 30, 2019	Upgrade Pro	Upgrade Pro
Dec 28, 2018	Upgrade Pro	Upgrade Pro
Dec 29, 2017	Upgrade Pro	Upgrade Pro
Dec 30, 2016	Upgrade Pro	Upgrade Pro

Market Capitalization

Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.

Formula: Market Cap = Stock Price * Shares Outstanding

Full Definition

Related Stocks

Company	Market Cap
SanBio Company	149.90B
GNI Group	142.90B
Takara Bio	98.26B
Nxera Pharma	76.74B
Cuorips	67.65B
Healios K.K.	44.09B
RaQualia Pharma	26.01B
AnGes	22.56B

Market Cap Rankings